- Home
- RCKY vs PRQR Comparison
RCKY vs PRQR Comparison
Compare RCKY & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKY
- PRQR
- Stock Information
- Founded
- RCKY 1932
- PRQR 2012
- Country
- RCKY United States
- PRQR Netherlands
- Employees
- RCKY N/A
- PRQR N/A
- Industry
- RCKY Shoe Manufacturing
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- RCKY Consumer Discretionary
- PRQR Health Care
- Exchange
- RCKY Nasdaq
- PRQR Nasdaq
- Market Cap
- RCKY 155.9M
- PRQR 179.1M
- IPO Year
- RCKY 1993
- PRQR 2014
- Fundamental
- Price
- RCKY $23.13
- PRQR $2.35
- Analyst Decision
- RCKY Hold
- PRQR Strong Buy
- Analyst Count
- RCKY 1
- PRQR 8
- Target Price
- RCKY $20.00
- PRQR $8.88
- AVG Volume (30 Days)
- RCKY 56.4K
- PRQR 346.0K
- Earning Date
- RCKY 07-29-2025
- PRQR 08-07-2025
- Dividend Yield
- RCKY 2.69%
- PRQR N/A
- EPS Growth
- RCKY 2.41
- PRQR N/A
- EPS
- RCKY 1.84
- PRQR N/A
- Revenue
- RCKY $454,939,000.00
- PRQR $21,212,711.00
- Revenue This Year
- RCKY $6.67
- PRQR N/A
- Revenue Next Year
- RCKY $4.25
- PRQR N/A
- P/E Ratio
- RCKY $12.52
- PRQR N/A
- Revenue Growth
- RCKY N/A
- PRQR 85.91
- 52 Week Low
- RCKY $11.93
- PRQR $1.07
- 52 Week High
- RCKY $37.80
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- RCKY 59.18
- PRQR 71.45
- Support Level
- RCKY $23.52
- PRQR $2.10
- Resistance Level
- RCKY $24.93
- PRQR $2.51
- Average True Range (ATR)
- RCKY 0.74
- PRQR 0.15
- MACD
- RCKY 0.08
- PRQR 0.03
- Stochastic Oscillator
- RCKY 70.75
- PRQR 82.41
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.